Stanewick Gerald T

Adhera Therapeutics, Inc.

Director

Avg. Two Year Performance

(38%) Avg. Purchase Return (18%) Compound

39% Avg. Sale Return 18% Compound

Holdings: 175.41K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions